Clinical Trials Browser

Phase 1 × veledimex × 1 year × Clear all

NCT03679754 2025-08-28

Evaluation of Ad-RTS-hIL-12 + Veledimex in Subjects With Recurrent or Progressive Glioblastoma, a Substudy to ATI001-102

Phase 1 Completed

36 enrolled 21 charts

Glioblastoma

NCT03636477 2025-08-12

A Study of Ad-RTS-hIL-12 With Veledimex in Combination With Nivolumab in Subjects With Glioblastoma; a Substudy to ATI001-102

Phase 1 Completed

21 enrolled 36 charts

Glioblastoma